Biocurity

At BioCurity Pharmaceuticals, we are a preclinical biotechnology company dedicated to transforming radiation therapy for cancer patients worldwide. Our mission is to prevent radiation side effects for cancer patients around the globe by developing supportive care oncology drugs that enhance treatment outcomes and improve the quality of life for cancer patients. We are committed to saving billions of dollars treating unwanted side effects.

Transforming Radiation Therapy

Our proprietary technology has the potential to prevent radiation treatment-related side effects without interfering with or reducing the effectiveness of radiation therapy on a patient's course of treatment. This technology recognizes the failure of the body's cellular protection and DNA repair mechanisms due to excessive levels of radiation-induced Reactive Oxygen Species (ROS) that cause damage to healthy cells. The nanoparticle technology used in our proprietary IV and topical formulations under development selectively degrade and remove these ROS from healthy cells, preventing cellular DNA damage.

The BioCurity Science

The scientific foundation of the BioCurity discovery recognizes the failure of the body's cellular protection and DNA repair mechanisms due to excessive levels of radiation-induced Reactive Oxygen Species (ROS) that cause damage to healthy cells. The nanoparticle technology used in our proprietary IV and topical formulations under development selectively degrade and remove these ROS from healthy cells, preventing cellular DNA damage. Our IV and topical formulation positive preclinical data in animal models indicate the potential use in multiple cancers.

Meet the Team

Our team is comprised of experienced professionals with a combined experience of over 150 years in international markets, drug development, and investment banking. Our leadership includes Sam Merchant, Co-Founder and Chairman of the Board, who has structured, negotiated, and executed transactions in the healthcare space through his past business experience with his Family office and affiliated companies. Our Medical and Scientific Advisory Board consists of some of the preeminent leaders in the fields of medical oncology and radiation therapy.

Our Mission and Purpose

Our mission is to prevent radiation side effects for cancer patients around the globe. We aim to enhance treatment outcomes and improve the quality of life for cancer patients, in addition to saving billions of dollars treating unwanted side effects. We believe that our proprietary technology has the potential to revolutionize radiation therapy and make a significant impact on the lives of cancer patients worldwide.